Australia markets closed

Alaunos Therapeutics, Inc. (TCRT)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.0700-0.0200 (-1.83%)
At close: 04:00PM EDT
1.1000 +0.03 (+2.80%)
After hours: 04:22PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 17.13M
Enterprise value 11.07M
Trailing P/E 4.35
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)191.68
Price/book (mrq)3.57
Enterprise value/revenue 1.85k
Enterprise value/EBITDA -3.55

Trading information

Stock price history

Beta (5Y monthly) -0.30
52-week change 3-84.49%
S&P500 52-week change 324.69%
52-week high 37.9500
52-week low 30.6000
50-day moving average 31.3440
200-day moving average 31.5899

Share statistics

Avg vol (3-month) 348.09k
Avg vol (10-day) 335.86k
Shares outstanding 516.01M
Implied shares outstanding 616.01M
Float 813.08M
% held by insiders 114.30%
% held by institutions 114.71%
Shares short (15 May 2024) 41.45M
Short ratio (15 May 2024) 437.28
Short % of float (15 May 2024) 410.54%
Short % of shares outstanding (15 May 2024) 49.07%
Shares short (prior month 15 Apr 2024) 41.46M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:15
Last split date 301 Feb 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-174,200.00%

Management effectiveness

Return on assets (ttm)-47.01%
Return on equity (ttm)-156.09%

Income statement

Revenue (ttm)6k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -18.94M
Net income avi to common (ttm)-26.77M
Diluted EPS (ttm)-32.4800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)4.14M
Total cash per share (mrq)0.26
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)4.87
Book value per share (mrq)0.30

Cash flow statement

Operating cash flow (ttm)-22.68M
Levered free cash flow (ttm)-569.38k